ki:elements develops speech based biomarkers for a number of different indications, including Alzheimer’s disease, Schizophrenia, COPD, and many more. We work with the leading life science companies to bring speech biomarkers into clinical trials and real world scenarios. ki:elements was founded in 2017 as a spin-off of the German Research Center for Artificial Intelligence as an interdisciplinary team of AI-experts, clinicians, software developers, and psychologists.